Methods of treating cell culture media for use in a bioreactor

What is this patent about?

’816 is related to the field of biopharmaceutical manufacturing and, more specifically, to the sterilization of liquid nutrients used to grow cell lines. In large-scale protein production, viral contamination of the growth environment can lead to catastrophic batch failures and costly facility shutdowns. While the industry has traditionally focused on viral clearance downstream—after the protein has already been produced—there is a critical need for robust, high-throughput methods to ensure that the media entering the bioreactor is free of pathogens without degrading the sensitive chemical components required for cell health.

The underlying idea behind ’816 is to implement a multi-stage decontamination protocol specifically at the upstream stage of the process, utilizing a precise dose of short-wave radiation to neutralize hardy viruses. The inventor recognized that while cell culture media is highly absorbent and difficult to penetrate with light, applying UVC light at a specific energy density can effectively shatter the genomic structure of non-enveloped viruses. By combining this targeted irradiation with mechanical filtration, the system creates a comprehensive barrier that addresses both small, resistant viral particles and larger contaminants before they ever reach the bioreactor.

The claims of ’816 focus on a method that subjects cell culture media to UVC light at a controlled energy density between 120-320 J/m2 followed by a sterile filtration step. Independent claim 1 covers this basic sequence of irradiation and sterile filtering prior to bioreactor entry. Independent claim 13 expands this process by inserting a depth filter into the sequence, which utilizes multiple layers of varying density to trap particulate matter and enveloped viruses through size exclusion and adsorption, providing an additional layer of protection before the final sterile filtration.

In practice, the invention works by passing the liquid media through a specialized reactor that generates Dean vortices—a type of hydraulic spiral flow—to ensure every part of the fluid is uniformly exposed to the UVC source. This uniform dosing is critical because it allows for a high enough energy density to achieve a significant log reduction in viral load without over-exposing the media to the point of nutrient degradation. The subsequent filtration steps then act as a physical safety net, removing any remaining viral debris or larger pathogens that survived the light treatment, resulting in a media stream that is biologically secure.

This approach differs from prior methods by shifting the focus from product purification to preventative upstream sterilization. Traditional techniques like 20 nm filtration or chromatography were often deemed too slow or expensive for the massive volumes of raw media required in 20,000 L bioreactors. By optimizing the UVC energy density and integrating it with depth filtration, the invention provides a high-flow, cost-effective solution that protects the cell line itself, rather than just cleaning the final protein harvest, thereby ensuring a more stable and efficient production environment.